AR
Andrew Rowan Ian Yee
About Andrew Rowan Ian Yee
Data last updated:
Andrew Rowan Ian Yee has 4 years in corporate governance. Holds Nominee Director role. Currently with 1 company, including Zenex Animal Health India Private Limited. Engaged in Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Zenex Animal Health India Private Limited at ₹1,023 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Zenex Animal Health India Private Limited U24299GJ2021PTC120998 | Nominee Director | 30 May 2022 | 2021 | ₹1,023 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Andrew Rowan Ian Yee
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Andrew Rowan Ian Yee
Andrew Rowan Ian Yee has 4 years in corporate governance. Holds Nominee Director role. Currently with 1 company, including Zenex Animal Health India Private Limited. Engaged in Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Zenex Animal Health India Private Limited at ₹1,023 Cr (FY 2025).
Andrew Rowan Ian Yee is associated with 1 company as Nominee Director, including Zenex Animal Health India Private Limited (₹1,023 Cr).
Andrew Rowan Ian Yee has expertise in Healthcare.
Andrew Rowan Ian Yee has 4 years in corporate governance.
By reported revenue, the largest current company of Andrew Rowan Ian Yee is Zenex Animal Health India Private Limited, with revenue of ₹1,023 Cr (FY 2025).
Andrew Rowan Ian Yee currently holds positions at 1 company: Zenex Animal Health India Private Limited (₹1,023 Cr).